High-Level Athletes With Borderline Hip Dysplasia Achieve Favorable Outcomes and Return to Sport Rates Following Primary Hip Arthroscopy
Authors: Owens JS, Jimenez AE, Lee MS, Monahan PF, Maldonado DR, Domb BG
Journal: Arthroscopy, February 2023
DOI: 10.1016/j.arthro.2022.08.023
Background
Outcomes of high-level athletes with borderline hip dysplasia (BHD) undergoing hip arthroscopy for labral pathology and femoroacetabular impingement syndrome were investigated.
Methods
- 34 athletes with BHD (LCEA 18°–25°) followed for a minimum of 5 years post-hip arthroscopy.
- Compared to athletes with normal acetabular coverage (LCEA 25°–40°).
Key Findings
- BHD athletes showed significant PRO improvements and 90% RTS rates.
- Achievement of minimal clinically important difference (MCID) was high.
- Outcomes and RTS rates were comparable between BHD athletes and those with normal coverage.
Conclusions
Hip arthroscopy offers favorable long-term outcomes and high RTS rates in athletes with borderline hip dysplasia, similar to those with normal acetabular anatomy.
What Does This Mean for Providers:
- Borderline hip dysplasia should not preclude hip arthroscopy for athletes with labral pathology and FAIS.
- Expect positive mid- to long-term functional outcomes and high RTS rates in this population.
- Patient selection and surgical planning should consider borderline dysplasia as a treatable condition with arthroscopy.